BioScience Health Innovations, Inc.
BHIC
$4.49
$0.4912.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -169.22% | -102.57% | 638.05% | 2,194.56% | 1,372.69% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -150.97% | -284.91% | -539.59% | -2,956.22% | -985.76% |
| Cash from Operations | -349.53% | -277.27% | 642.24% | 1,209.41% | 682.58% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.57% | 51.96% | -118.85% | -830.00% | -- |
| Cash from Investing | 47.57% | 51.96% | -118.85% | -830.00% | -- |
| Total Debt Issued | 24.10% | 142.87% | 216.38% | 183.54% | 127.28% |
| Total Debt Repaid | -15.04% | -113.37% | -195.05% | -151.54% | -99.82% |
| Issuance of Common Stock | 33.33% | -24.64% | -- | 40.00% | 81.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.02% | 43.91% | -117.94% | 130.69% | 179.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.80% | -87.52% | -100.09% | 176.85% | 917.17% |